
Flow Neuroscience
Flow Neuroscience is pioneering a new category of at-home electric medicine and delivering drug-free, brain-based treatments for mental health. Flow is world’s first clinically validated FDA approved at-home transcranial direct current stimulation (tDCS) headset. Since its European launch in 2019, Flow has become the only CE-marked at-home tDCS treatment for depression used by the NHS, empowering more than 55,000 people to take control of their mental health. With FDA approval in 2025, the US joins the UAE, Australia, Brazil, the UK and EU as countries where Flow’s accessible depression treatment is available.